Annual Reports
Annual Report – 2018/2019
Wesley Medical Research Annual Report 2018-2019 Download Annual report Read the Report Online
Menu
Menu
Wesley Medical Research Annual Report 2018-2019 Download Annual report Read the Report Online
Did you know that rare diseases are actually common? There are about 8000 rare diseases affecting an estimated 1.5 million Australians.
At this special Advocates Event, Associate Professor Robert Henderson and Professor David Coman will detail some research they are working on to give people with rare diseases better treatment options and offer a better quality of life.
In 2017 Kym’s life was full and happy. But what Kym didn’t know was that a rare genetic disease, Porphyria, was now waking within her body. A clinical trial for a new therapy is providing hope that life could return to normal.
On January 10, Wesley Medical Research hosts an annual celebration with family and friends of the Justin Cameron Cancer Care Foundation.
Research tackling the growing obesity problem in Emerald, Central Queensland.
A new clinical trial is set to explore the efficacy of a new form of treatment using a device called the Enhanced Lithotripsy System (ELS) for urinary stones.
Cardiologist Dr Ben Fitzgerald is seeking to identify differences in cardiac characteristics between patients who respond to treatment and those who do not in the hope of determining which patients will be more likely to respond to therapy
Prostate cancer is the third most common cause of death in Australia, with 20,000 diagnoses and close to 3,300 deaths each year. A novel prostate cancer trial is delivering more options for patients.
Member for Moggill Dr Christan Rowan recently tabled a Private Members Statement in Parliament to commemorate the 25th Anniversary of Wesley Medical Research. The statement
On November 4th, at a special reception hosted by His Excellency the Honourable Paul de Jersey AC, Governor of Queensland at Government House, stakeholders gathered to celebrate the launch of the 25th year of making a difference through medical research.
After trying a dozen different medications, Chris, a Brisbane man who was diagnosed with debilitating Tourette’s Syndrome at age 12, is part of an Australian-first medicinal cannabis trial. For the past 16 years, the condition has impacted all aspects of Chris’ life, including his mental health. This trial has offered Chris more than hope. It’s offered a future.
These photos were taken at our Advocates Event – Straight to the Heart: Cardiac Research Saving Lives.
